ライフサイエンスコーパス: endothelial progenitor

1 fferentiation, and molecular profiling of an endothelial progenitor.

2 l that originates in bone marrow, a putative endothelial progenitor.

3 NOTCH1 silencing blocks the transition into endothelial progenitors.

4 lay a crucial role in the differentiation of endothelial progenitors.

5 initive hematopoietic progenitors as well as endothelial progenitors.

6 ic stem cells, mesenchymal stromal cells and endothelial progenitors.

7 s that did not receive MFSD2A-overexpressing endothelial progenitors.

8 proposal suggests that neovessels form from endothelial progenitors able to assemble the intimal lay

9 xpressed markers consistent with circulating endothelial progenitors and synthesized high levels of p

10 that renal cortices of newborn mice contain endothelial progenitors (angioblasts) and that when embr

11 ecified in the somite at forelimb level, but endothelial progenitors are absent.

12 Myo-endothelial progenitors are the most affected cell type:

13 xpressing cells that show characteristics of endothelial progenitors capable of maturation into endot

14 PCs with osteogenic properties carrying both endothelial progenitor (CD34, KDR) and osteoblastic (ost

15 n in primary tumors, including expression of endothelial progenitor cell (CD133 and CD34) and endothe

16 n of ADAM17, modulates postnatal circulating endothelial progenitor cell (CEPC) numbers via effects o

17 w PA diabetic (d-PA) concentrations affected endothelial progenitor cell (EPC) and bone marrow-derive

18 Endothelial progenitor cell (EPC) counts are proposed su

19 regard to endothelial vasodilatory function, endothelial progenitor cell (EPC) function, in vivo neoa

20 y increased vascular senescence and impaired endothelial progenitor cell (EPC) function.

21 ine human microvascular EC (HMVEC) and human endothelial progenitor cell (EPC) recruitment into engra

22 wound closure rates, neovascularization, and endothelial progenitor cell (EPC) recruitment.

23 gical effects after bone marrow (BM)-derived endothelial progenitor cell (EPC) transplantation into i

24 cumented the role of SIRT1 in reduced EC and endothelial progenitor cell (EPC) viability.

25 h-mobility-group-box-1 (HMGB1) that promotes endothelial progenitor cell (EPC)-mediated neurovascular

26 impaired Lin(-)cKit(+)Sca1(+) (LKS) cell and endothelial progenitor cell (EPC; CD34(+)Flk1(+)) mobili

27 mal cell sheets (hMSC) as the wall and human endothelial progenitor cell (hEPC) coating as the lumen.

28 tem that sustains the release of a bioactive endothelial progenitor cell chemokine during a 4-week pe

29 eeks in vitro, remained active, and enhanced endothelial progenitor cell chemotaxis.

30 t peripheral blood (PB) cytokines predict BM endothelial progenitor cell colony outgrowth and cardiac

31 ogenitor cell mobilization from bone marrow, endothelial progenitor cell differentiation, and ultimat

32 exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be ident

33 ent vasorelaxation of thoracic aortas and in endothelial progenitor cell function, as assessed by the

34 tric oxide (NO) is a key regulator of EC and endothelial progenitor cell function, but the pathophysi

35 release of SDF-1, a chemokine that promotes endothelial progenitor cell homing and angiogenesis, fro

36 Since the identification of the endothelial progenitor cell in 1997 by Asahara and Isner

37 sFlt1 with concomitant decreased circulating endothelial progenitor cell levels along with inappropri

38 Baseline flow-mediated dilation and endothelial progenitor cell levels were lower in patient

39 Circulating endothelial progenitor cell levels were quantified to as

40 scular endothelial growth factor expression, endothelial progenitor cell mobilization from bone marro

41 roliferative capacity of ECs and circulating endothelial progenitor cell numbers after vascular injur

42 glitazone in improving endothelial function, endothelial progenitor cell numbers and functional capac

43 d Notch signaling increased Prox1+ lymphatic endothelial progenitor cell numbers in the veins, leadin

44 under oxidative stress, as well as decreased endothelial progenitor cell numbers were responsible for

45 and significantly increased Prox1+ lymphatic endothelial progenitor cell numbers.

46 Participants underwent endothelial progenitor cell phenotyping with an early-ou

47 Multicolor flow cytometry quantified the endothelial progenitor cell population in the bone marro

48 further enriched by selection for a CD133(+) endothelial progenitor cell population.

49 The endothelial progenitor cell recently emerged as an impor

50 Specifically, endothelial cell/endothelial progenitor cell survival, vascular endotheli

51 g tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not res

52 ), and group 5 (combined bone marrow-derived endothelial progenitor cell-extracorporeal shock wave) a

53 present study suggests that ischemia-induced endothelial progenitor cell-mediated neovascularization

54 ently, it remains controversial how vascular endothelial progenitor cells (angioblasts) establish the

55 We discovered that bone marrow-derived endothelial progenitor cells (BM-EPC), having the phenot

56 ating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs).

57 as well as numbers of inflammatory cells and endothelial progenitor cells (c-kit+/CD31+ cells) in bot

58 Circulating endothelial progenitor cells (cEPCs) are known to contri

59 more, conditioned medium (CM) from embryonic endothelial progenitor cells (eEPCs) rescued the follicu

60 ndothelial cells, thus tethering circulating endothelial progenitor cells (EPC) and facilitating homi

61 Endothelial progenitor cells (EPC) are able to migrate t

62 Bone marrow-derived endothelial progenitor cells (EPC) contribute to the ang

63 s (GSKi) can improve therapeutic efficacy of endothelial progenitor cells (EPC) from patients with DM

64 cal animal models, early clinical studies of endothelial progenitor cells (EPC) have begun.

65 derived from the intended recipient--either endothelial progenitor cells (EPC) or endothelial cell (

66 (SDF-1alpha, a homing signal for recruiting endothelial progenitor cells (EPC) to areas of neovascul

67 Homing of endothelial progenitor cells (EPC) to the ischemic tissu

68 Endothelial progenitor cells (EPC) were successfully cul

69 angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC).

70 d cancer progression for bone marrow-derived endothelial progenitor cells (EPC).

71 ed to the recruitment of bone marrow-derived endothelial progenitor cells (EPC).

72 otransplantation of peripheral blood-derived endothelial progenitor cells (EPCs) and bone marrow-deri

73 to impairments in vascular repair induced by endothelial progenitor cells (EPCs) and circulating angi

74 s were supported by in vitro observations on endothelial progenitor cells (EPCs) and endothelial cell

75 and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angioge

76 ll apoptosis and vascular repair mediated by endothelial progenitor cells (EPCs) and myeloid circulat

77 Endothelial progenitor cells (EPCs) and myelomonocytic c

78 The number of circulating endothelial progenitor cells (EPCs) and plasma levels of

79 ed the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from n

80 Endothelial progenitor cells (EPCs) are a heterogeneous

81 l cells, and form new vessels, blood-derived endothelial progenitor cells (EPCs) are attractive sourc

82 rculating progenitor cells (CPCs), including endothelial progenitor cells (EPCs) are biologically rel

83 Endothelial progenitor cells (EPCs) are decreased in num

84 Endothelial progenitor cells (EPCs) are essential in vas

85 Marrow-derived endothelial progenitor cells (EPCs) are important in the

86 Mobilization and functions of endothelial progenitor cells (EPCs) are increased in pat

87 Endothelial progenitor cells (EPCs) are known to promote

88 Endothelial progenitor cells (EPCs) are present in the s

89 Diverse subsets of endothelial progenitor cells (EPCs) are used for the tre

90 stasis, we identify bone marrow (BM)-derived endothelial progenitor cells (EPCs) as critical regulato

91 ct MVs shed from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbe

92 ic platform capable of capturing circulating endothelial progenitor cells (EPCs) by understanding sur

93 by extracellular matrix scaffold seeded with endothelial progenitor cells (EPCs) can overcome these l

94 Endothelial progenitor cells (EPCs) can participate with

95 Endothelial progenitor cells (EPCs) contribute to postna

96 Endothelial progenitor cells (EPCs) contribute to vascul

97 etic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly

98 D133(+) and CD34(+) CPCs as well as cultured endothelial progenitor cells (EPCs) derived from blood m

99 Endothelial progenitor cells (EPCs) enter the systemic c

100 therosclerosis have increases in circulating endothelial progenitor cells (EPCs) expressing an osteog

101 siderable interest in exploiting circulating endothelial progenitor cells (EPCs) for therapeutic orga

102 We have previously shown that human endothelial progenitor cells (EPCs) form functioning ves

103 infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow

104 xia enhances the mobilization of circulating endothelial progenitor cells (EPCs) from the bone marrow

105 n in the control of regenerative function of endothelial progenitor cells (EPCs) has not been studied

106 Reduced levels of endothelial progenitor cells (EPCs) have been associated

107 Endothelial progenitor cells (EPCs) have been associated

108 Although different substances that mobilize endothelial progenitor cells (EPCs) have been proposed,

109 Endothelial progenitor cells (EPCs) have been shown to a

110 We hypothesize that blood-derived endothelial progenitor cells (EPCs) have the required pr

111 Little is known about the role of endothelial progenitor cells (EPCs) in atherosclerosis.

112 Endothelial progenitor cells (EPCs) in ESA gradient, ass

113 The discovery of endothelial progenitor cells (EPCs) in human peripheral

114 ggest a critical role of bone marrow-derived endothelial progenitor cells (EPCs) in neovascularizatio

115 Diabetic individuals have fewer endothelial progenitor cells (EPCs) in their circulation

116 Migration of endothelial progenitor cells (EPCs) into areas of vascul

117 The incorporation of endothelial progenitor cells (EPCs) into microvessels co

118 The incorporation of endothelial progenitor cells (EPCs) into newly developin

119 Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging conce

120 Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging thera

121 Vascular repair by marrow-derived endothelial progenitor cells (EPCs) is impaired during d

122 d on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known.

123 Endothelial progenitor cells (EPCs) may be relevant cont

124 Endothelial progenitor cells (EPCs) normally augment ang

125 (SHS) exposure on the number and function of endothelial progenitor cells (EPCs) over 24 h.

126 Because endothelial progenitor cells (EPCs) participate in this

127 In adults, circulating endothelial progenitor cells (EPCs) participate in vascu

128 Endothelial progenitor cells (EPCs) play a critical role

129 Endothelial progenitor cells (EPCs) play an important ro

130 Endothelial progenitor cells (EPCs) promote neovasculari

131 and circulating progenitor cells (CPCs) and endothelial progenitor cells (EPCs) PTH, and genetic par

132 Late outgrowth endothelial progenitor cells (EPCs) represent a promisin

133 only isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion t

134 n (TBI) and then infused with C57Bl6-derived endothelial progenitor cells (EPCs) to augment endogenou

135 Endothelial progenitor cells (EPCs) was assayed by flow

136 Endothelial progenitor cells (EPCs) were cultured on the

137 carotid arteries and circulating numbers of endothelial progenitor cells (EPCs) were examined after

138 Circulating endothelial progenitor cells (EPCs) were quantified at b

139 e number of bone marrow and peripheral blood endothelial progenitor cells (EPCs), a marker of vascula

140 ase, by causing a reduction in the number of endothelial progenitor cells (EPCs), bone marrow-derived

141 Flow cytometry was applied to quantify endothelial progenitor cells (EPCs), circulating endothe

142 Endothelial progenitor cells (EPCs), critical for mediat

143 Endothelial progenitor cells (EPCs), defined as CD34(+)V

144 We hypothesized that adriamycin affects endothelial progenitor cells (EPCs), leading to impaired

145 at PAH patients are deficient in circulating endothelial progenitor cells (EPCs), potentially contrib

146 nclude endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs), respectively.

147 Since the discovery of endothelial progenitor cells (EPCs), there have been con

148 the mobilization of bone marrow (BM)-derived endothelial progenitor cells (EPCs), thereby enhancing n

149 is associated with a deficit of circulating endothelial progenitor cells (EPCs), which has been attr

150 have profound effects on the endothelium and endothelial progenitor cells (EPCs), which originate fro

151 etic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain

152 eovascularization is controversial, but BMD--endothelial progenitor cells (EPCs)--are strongly implic

153 cells (CECs), angiogenic growth factors, and endothelial progenitor cells (EPCs).

154 e-induced recruitment of bone marrow-derived endothelial progenitor cells (EPCs).

155 Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs).

156 novo recruitment of bone marrow (BM)-derived endothelial progenitor cells (EPCs).

157 repair by regenerative endothelial cells and endothelial progenitor cells (EPCs).

158 layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPCs) from a separate,

159 Human endothelial progenitor cells (hEPCs) participate in neov

160 ylation in cord blood-derived late outgrowth endothelial progenitor cells (OEPCs).

161 Endometriotic lesions increased circulating endothelial progenitor cells 13 days after engraftment,

162 eated with intramuscular bone marrow-derived endothelial progenitor cells [2.0 x 10 cells]), group 4

163 e of a role for bone marrow-derived putative endothelial progenitor cells after iatrogenic vascular i

164 to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribron

165 ntly increased numbers of VEGFR2(+)/AC133(+) endothelial progenitor cells and CD34(+)/VEGFR1(+) hemat

166 Combined treatment with bone marrow-derived endothelial progenitor cells and extracorporeal shock wa

167 Next, resident endothelial progenitor cells and hematopoietic stem cell

168 Exogenous uric acid rapidly mobilizes endothelial progenitor cells and hematopoietic stem cell

169 l plaque volume but does stabilize levels of endothelial progenitor cells and improve microvascular f

170 r analog [ESA]) induces continuous homing of endothelial progenitor cells and improves left ventricul

171 nrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnata

172 actor-1 (SDF-1) is a chemokine that attracts endothelial progenitor cells and promotes angiogenesis.

173 IL-1beta and IL-18, and coadministration of endothelial progenitor cells and stromal cell-derived fa

174 stigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic

175 s process is recapitulated in the adult when endothelial progenitor cells are generated in the bone m

176 or cells, rhG-CSF can mobilize dendritic and endothelial progenitor cells as well.

177 rentiated them to both endothelial cells and endothelial progenitor cells by using the embryoid body

178 Endothelial progenitor cells can restore vessel wall fun

179 forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis i

180 Endothelial progenitor cells contribute to vascular repa

181 Endothelial/endothelial progenitor cells derived from iPS cells expr

182 etwork mediating developmental plasticity of endothelial progenitor cells during embryonic developmen

183 During embryogenesis, lymphatic endothelial progenitor cells first arise from a subset o

184 we demonstrate the isolation of CD34+/Flk1+ endothelial progenitor cells from blood enabled by the d

185 ically engineered mesenchymal stem cells and endothelial progenitor cells has been explored as a rege

186 In this new field, characterization of endothelial progenitor cells has presented new opportuni

187 e assessed at multiple time points using rat endothelial progenitor cells in a transwell migration as

188 mor progression have 2-fold more circulating endothelial progenitor cells in peripheral blood than co

189 tometry was performed to measure circulating endothelial progenitor cells in peripheral blood.

190 The miR array data from endothelial progenitor cells in response to inflammatory

191 is expressed in tumor neovasculature and on endothelial progenitor cells in the bone marrow, was lab

192 , exhibited an increased number of lymphatic endothelial progenitor cells in the cardinal veins, toge

193 ining the role of murine bone marrow-derived endothelial progenitor cells in the process of tumor neo

194 This correlated with a 30% increase in endothelial progenitor cells in the retina at postnatal

195 By contrasting the role of endothelial progenitor cells in tissue regeneration with

196 lary density, as well as bone marrow-derived endothelial progenitor cells incorporation into the func

197 In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the pot

198 ance by CYP26B1 in the vicinity of lymphatic endothelial progenitor cells is important for determinin

199 Late outgrowth endothelial progenitor cells isolated from HPAH patients

200 Further evidence suggests that stem cells or endothelial progenitor cells may be released from both b

201 vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proathero

202 corporeal shock wave and bone marrow-derived endothelial progenitor cells might exert enhanced protec

203 ECs expanded from blood-derived endothelial progenitor cells of VWD patients confirmed t

204 ve is superior to either bone marrow-derived endothelial progenitor cells or extracorporeal shock wav

205 eproduced in vitro by incubation of cultured endothelial progenitor cells or spleen-derived endotheli

206 Delivery of endothelial progenitor cells overexpressing endothelial

207 To clarify the origin of endothelial progenitor cells participating in endothelia

208 Putative endothelial progenitor cells play a role in organ regene

209 ng living individuals, and its knock-down in endothelial progenitor cells precludes their capacity to

210 It has been demonstrated that endothelial progenitor cells present in the blood have a

211 e enhancer identified here becomes active in endothelial progenitor cells shortly after their initial

212 ain reaction and generated higher numbers of endothelial progenitor cells than CD31(-) cells did.

213 s study provides strong evidence in neonatal endothelial progenitor cells that GDM exposure in utero

214 abolites by gut endothelium requires MFSD2A; endothelial progenitor cells that overexpress MFSD2A red

215 Human circulating endothelial progenitor cells that overexpress MFSD2A wer

216 In mice with colitis, transplanted endothelial progenitor cells that overexpressed MFSD2A n

217 ls of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into matur

218 essed by the capacity of bone marrow-derived endothelial progenitor cells to differentiate into matur

219 en restored the resistance of both BMDCs and endothelial progenitor cells to oxidative stress, improv

220 ineered vessel can be seeded with autologous endothelial progenitor cells to provide a biological vas

221 the migration, recruitment, and retention of endothelial progenitor cells to sites of ischemic injury

222 igration of green fluorescent protein-tagged endothelial progenitor cells to tumor tissues.

223 Enhanced apoptosis of endothelial progenitor cells under oxidative stress, as

224 ized green fluorescent protein-Tie2-positive endothelial progenitor cells versus controls, with a cor

225 The Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

226 with CLI (n=33) included in the Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

227 flammatory stimuli, the miR array profile of endothelial progenitor cells was analyzed using a polyme

228 he number of circulating bone marrow-derived endothelial progenitor cells was significantly reduced i

229 Endothelial progenitor cells were CD31+, vWF+, and alpha

230 Endothelial progenitor cells were not observed along the

231 The implanted endothelial progenitor cells were restricted to the lumi

232 Characterized ovine peripheral blood endothelial progenitor cells were seeded onto scaffolds

233 uch a lentiviral vector can be used to endow endothelial progenitor cells with anti-tumor properties.

234 udy was to determine the role of circulating endothelial progenitor cells with osteoblastic phenotype

235 us mechanism of Hh signaling in angioblasts (endothelial progenitor cells) during arterial-venous spe

236 ycerol sebacate)) with a single cell source (endothelial progenitor cells).

237 icity of cardiac fibroblasts and circulating endothelial progenitor cells, and consider what role the

238 ty over the precise identity and function of endothelial progenitor cells, and harnessing their thera

239 es consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells

240 Signaling between endothelial cells, endothelial progenitor cells, and stromal cells is cruci

241 d cardiovascular progenitor cells, including endothelial progenitor cells, are capable of replacing d

242 The CACs, also termed endothelial progenitor cells, are critical for vascular

243 Endothelial progenitor cells, as well as HSC/HPCs, were

244 ndothelial nitric oxide synthase-transfected endothelial progenitor cells, divided into 3 doses on co

245 bone marrow-derived cell populations, called endothelial progenitor cells, have been reported to poss

246 the differentiation capacity of bone marrow endothelial progenitor cells, improved endothelium-depen

247 g promotes differentiation and maturation of endothelial progenitor cells, its role in the differenti

248 However, in contrast to endothelial progenitor cells, mature LSECs express littl

249 ecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular

250 ypes, including hematopoietic stem cells and endothelial progenitor cells, more efficiently than the

251 such as peripheral hematopoietic stem cells, endothelial progenitor cells, or circulating tumor cells

252 ematopoietic stem cells and depleted splenic endothelial progenitor cells, partially reproducing the

253 Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and M

254 pecimen was performed for endothelial cells, endothelial progenitor cells, smooth muscle cells, and i

255 study of the tolerability of culture-derived endothelial progenitor cells, transiently transfected wi

256 including RhoA/Rho kinase, tyrosine kinase, endothelial progenitor cells, vasoactive intestinal pept

257 homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis,

258 e that hematopoietic tissues are a source of endothelial progenitor cells, which contribute to newly

259 ed cellularity and altered the phenotypes of endothelial progenitor cells, which resulted in changes

260 ncy is associated with decreased circulating endothelial progenitor cells-like CD31(+)/c-Kit(+) cells

261 linase in microparticle-induced apoptosis of endothelial progenitor cells.

262 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

263 lial marker CD31, suggesting the presence of endothelial progenitor cells.

264 in these hematopoietic tissues gives rise to endothelial progenitor cells.

265 epletion restores the functional capacity of endothelial progenitor cells.

266 It has also been used to identify endothelial progenitor cells.

267 associated with mobilization of circulating endothelial progenitor cells.

268 t abnormalities in phenotype and function of endothelial progenitor cells.

269 f promoting endothelial regeneration through endothelial progenitor cells.

270 th tumor endothelial and bone marrow-derived endothelial progenitor cells.

271 of edema, and depletion of regulatory T and endothelial progenitor cells.

272 cripts in ischemic tissue and in circulating endothelial progenitor cells.

273 ng a mixture of cardiac progenitor cells and endothelial progenitor cells.

274 ability to differentiate into erythroid and endothelial progenitor cells.

275 sources, including bone marrow (circulating endothelial progenitors; CEP), and established vasculatu

276 profiles in the CD133(+) tumour cells, their endothelial progenitor derivatives and mature endotheliu

277 r importance is TLR4-mediated recruitment of endothelial progenitors derived from immature myeloid ce

278 r, we demonstrate that Notch is activated in endothelial progenitors during vasculogenesis prior to b

279 ted receptors and alphaVbeta3-overexpressing endothelial progenitor EP cells) and the kinase inhibito

280 g might play an important role in specifying endothelial progenitors from the mesoderm, given that th

281 artery pressure, whereas levels of resident endothelial progenitors in IPAH pulmonary arteries were

282 ft in our understanding of vascular-resident endothelial progenitors in tissue regeneration opens new

283 mobilized microparticles prolong survival of endothelial progenitors in vitro and in vivo by downregu

284 We here aimed to define vessel-resident endothelial progenitors in vivo in a variety of tissues

285 Furthermore, we find that endothelial progenitors in which Notch is activated are

286 Moreover, transfer of purified BM endothelial progenitors instead of whole BM cells sustai

287 ing VEGFR2 inhibits the maturation of tumour endothelial progenitors into endothelium but not the dif

288 promoting premature release of KSHV-infected endothelial progenitors into the circulation.

289 Although purified HSPCs acquired endothelial progenitor markers once recruited to the kid

290 Therapies designed to mobilize endothelial progenitors or to increase their ability to

291 ESA induced greater chemotaxis of endothelial progenitor stem cells compared with saline (

292 y designed peptide ESA induces chemotaxis of endothelial progenitor stem cells, stimulates neovasculo

293 markably, rQT3 treatment reduced circulating endothelial progenitors, suggesting virus-mediated antiv

294 proangiogenic precursors and tissue-resident endothelial progenitors to vascular remodeling in IPAH.

295 echanisms, de novo formation of vessels from endothelial progenitors (vasculogenesis) and sprouting o

296 t the differentiation of CD133(+) cells into endothelial progenitors, whereas gamma-secretase inhibit

297 resulted in a fraction expressing markers of endothelial progenitors while another fraction expressed

298 Thus, myo-endothelial progenitors with functioning Bmpr1a signalli

299 to identity the origin of endothelial progenitors within the hematopoietic hierarc

300 endothelial cells by limiting the number of endothelial progenitors within the mesoderm, probably fu